Greg Goldgof retweeted
Our preprint on #COVID19 seroprevalence and patient Ab dynamics in the #BayArea is out! 3 key findings: 0.1% seroprevalence in #BayArea March 2020. Ab neut titers rise with IgG/IgM-median seroconversion 10.3-11.0 d, immunocompromised pt with delayed Ab. medrxiv.org/content/10.1101/…
Greg Goldgof retweeted
AI in pathology is a hot topic! Join Faisal Mahmood @AI4Pathology from @harvardmed at noon ET on Friday, May 1 for Virtual Pathology Grand Rounds. Hosted by @UCSFHospitals, CME by @ASCP_Chicago. Register in advance (REQUIRED): bit.ly/2KsW60f #pathology #VirtualPathGR
Greg Goldgof retweeted
One of the fastest-growing AI applications is medicine. I'm excited to announce Courses 1&2 of @deeplearningai_‘s new AI For Medicine Specialization are now available on @Coursera! You’ll learn to diagnose from X-rays and build your own prognostic models: bit.ly/3aIsTdb
Greg Goldgof retweeted
Can we predict Total Knee Replacement onset in 5 years in subjects without OA from MRI and clinical data ? nature.com/articles/s41598-0… @UCSF_Ci2 @UCSFimaging
Greg Goldgof retweeted
An exceptional timely review of the #COVID19 diagnostic tests, including the @US_FDA EUA tests as 4 of April, use cases & future directions annals.org/aim/fullarticle/2……
@AnnalsofIM by @MatthewPCheng @cusm_muhc
and colleagues
Greg Goldgof retweeted
Thanks @businessinsider and @jesse_yeji for covering the work we're doing using @Apple iPads and @zoom_us to manage COVID-19 patients in the ED at @StanfordHealth ! businessinsider.com/stanford…










